"Perhaps this speaks to the long-term mindset of Bill Gates, likely instilled by the great Oracle of Omaha. In any case, Bill Gates' foundation only made one buy in the second quarter, and it was a big one. In case you missed it, his foundation added significantly to its position in Berkshire Hathaway ( NYSE:BRK-B) by less than 7 million shares."
"It's a diversified conglomerate that's cash-rich and ready to make deals should opportunities become more abundant. In today's arguably pricey market, Berkshire stands out as a way to get less exposure to the most heated parts of the tech sector with optionality to make bigger splashes should valuations begin to really come in, perhaps come the next correction or bear market. Indeed, Berkshire's $9.7 billion OxyChem acquisition has been praised by many pundits as a pretty good deal."
Bill Gates' Bill & Melinda Gates Foundation Trust holds steady, well-run businesses intended for extremely long-term performance. The foundation rarely trades, completing only three moves in the first two quarters and a single, substantial purchase in Q2. The Q2 transaction increased the foundation's Berkshire Hathaway position by under 7 million shares, elevating Berkshire to the trust's second-largest holding with weighting just below 25 percent. Berkshire's diversified, cash-rich structure enables opportunistic acquisitions, reduces concentrated tech exposure, and provides optionality to capitalize on market dislocations, exemplified by its $9.7 billion OxyChem acquisition.
#berkshire-hathaway #bill--melinda-gates-foundation-trust #long-term-investing #portfolio-allocation
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]